PMCF Study to Evaluate Performance and Safety of "Hyaluronic Acid (HA)-Based Eyedrops" Used to Relieve Dry Eye Symptoms
Dry Eye, Dry Eye Disease, Kerato Conjunctivitis Sicca
About this trial
This is an interventional treatment trial for Dry Eye
Eligibility Criteria
Inclusion Criteria: Patient Informed consent form (ICF) signed; Male & Female Aged ≥ 18 years at the time of the signature of the ICF; Patients with ophthalmic discomfort due to dry eye for intrinsic and/or extrinsic causes, contact lenses wearing and/or eye surgery; WIlling not to use other eye drops during the entire treatment period. Exclusion Criteria: Other - different - eyes clinical conditions (e.g. glaucoma); Suspected alcohol or drug abuse; Known hypersensitivity or allergy to IP components; Other clinically significant and uncontrolled pathologies that may interfere with study results (e.g. rheumatic diseases, diabetes); Participation in another investigational study; Inability to follow all study procedures, including attending all site visits, tests and examinations; Mental incapacity that precludes adequate understanding or cooperation.
Sites / Locations
- Azienda Ospedaliero-Universitaria Policlinico "G.Rodolico - San Marco"Recruiting
Arms of the Study
Arm 1
Experimental
Eyedrops treatment arm